Biotech industry wins some concessions on GMO rules

The Government has rejected assertions in a report by the House of Lords Select Committee on Science and Technology that excessive regulation has placed the UK's biotechnology industry at a competitive disadvantage. But its response shows that an increasing number of deregulatory moves are now in place or in the pipeline.1

Sorry you do not have access to this article. Please contact Customer Support at
or call 020 8267 8120

The ENDS Report - subscribe today